Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid
(Corrects spelling of Metsera in first sub-header) By Kamal Choudhury, Sabrina Valle and Tom Hals (Reuters) -Pfizer on Friday filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations in declaring the Danish drugmaker’s $8.5 billion bid for the U.S. obesity drug developer to be a superior offer. Pfizer asked …
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid Read More »










